Skip to main content
. 2007 Jun 4;2:25. doi: 10.1186/1749-8090-2-25

Table 5.

Postoperative complications

Complications Diprospan group Placebo group Control group P value* P value*?
Pulmonary
-Bronchospasm 2 3 1
-Pneumonia 1 1 1
-Atelectasis 1 0 0
-Pleural effusion 1 0 2
-Pneumothorax 0 1 0
-Respiratory failure 1 1 1
Total pulmonary 6(20%) 6 (20%) 5 (10%) 0.56 0.02
Nonpulmonary
Major
- Wound infection 2 4 0
- Acute renal failure 1 0 0
- Stroke 1 2 0
- Sepsis 0 1 0
- Re-surgery 1 1 2
Total major 5 (17%) 8 (26%) 2 (7%) 0.8 0.03
Minor
- Atrial 11 8 1
tachyarrhythmias -
Superficial wound 4 3 4
 infection
- Transient oliguria 1 2 3
- Urinary tract infection 0 1 0
- Acute gout 0 1 0
Total minor 16 (53%) 15 (50%) 8 (27%) 0.1 0.01
Total nonpulmonary 21 (70%) 23 (76%) 10 (33%) 0.79 0.01

* Between Diprospan and placebo groups.

** Between Control and COPD groups.